Peripheral Artery Disease in Canada: A Patient's Guide

How Common Is PAD in Canada?

Peripheral Artery Disease affects an estimated 850,000 to 1 million Canadians — though because many cases are asymptomatic, the true number is likely higher. The disease burden follows the same demographic patterns as in the USA:

Exterior of a Canadian healthcare facility representing CCS guidelines and provincial resources.

• Prevalence increases dramatically with age — affecting approximately 2–3% of Canadians aged 40–50 and rising to 15–20% of those over 70
• Smoking is the leading modifiable risk factor — and while Canadian smoking rates have fallen to approximately 11% (Statistics Canada, 2023), the legacy burden of past smokers is substantial
• Type 2 diabetes affects approximately 4 million Canadians (Diabetes Canada, 2023) and an additional 5.7 million have prediabetes — this large population carries significantly elevated PAD risk
• Hypertension affects approximately 7.5 million Canadian adults

A 2023 analysis of Canadian administrative health data found that PAD diagnosis rates in Canada have increased approximately 15% over the past decade, partly reflecting improved detection and partly representing genuine increases in disease burden driven by the aging of the baby boom generation and the growing diabetes epidemic.

Canadian Cardiovascular Society (CCS) Guidelines for PAD

The Canadian Cardiovascular Society (CCS) published its most recent comprehensive guidelines on peripheral vascular disease management in 2022, with updates through 2024. Key Canadian guideline recommendations align closely with the 2024 ACC/AHA guidelines while reflecting Canadian healthcare system realities:

Screening Recommendations

• ABI testing is recommended for Canadians over 50 with diabetes or a smoking history
• ABI should be considered for all adults over 65, even without symptoms
• In patients with arterial calcification (ABI >1.4), TBI should be performed — available through most major Canadian vascular labs

Treatment Priorities (CCS)

• Risk factor modification first: Smoking cessation programs, statin therapy, blood pressure management, and diabetes control are the foundation of PAD treatment in Canada
• Antiplatelet therapy: Aspirin or clopidogrel for all patients with symptomatic PAD
• Supervised exercise: The CCS supports supervised exercise therapy as a first-line intervention, though notes that access varies significantly by province and region
• Revascularization: Endovascular and surgical options are available at major vascular centers across Canada

The full CCS guidelines are available at ccs.ca.

Provincial Health Coverage for PAD in Canada

Because Canada's healthcare system operates through 13 separate provincial and territorial plans, coverage for PAD testing and treatment varies. Here's a province-by-province overview:

Ontario (OHIP)

OHIP covers ABI testing when ordered by a physician for medically necessary indications. Vascular testing is available at Ontario's 14 Regional Vascular Programs, which are organized around major academic health centers (University Health Network in Toronto, London Health Sciences Centre, Ottawa Hospital Civic Campus, etc.). Wait times for outpatient ABI testing typically range from 2–8 weeks. Vascular specialist appointments typically have wait times of 4–12 weeks for non-urgent referrals.

British Columbia (MSP)

MSP covers ABI and vascular studies when medically indicated. BC's vascular care is centered at major urban hospitals — Vancouver General Hospital, St. Paul's Hospital, and Royal Jubilee Hospital in Victoria. Rural patients often face significantly longer travel distances and wait times. The BC Vascular Surgery program maintains a provincial referral network.

Alberta (AHCIP)

Alberta Health Insurance Plan covers medically necessary vascular testing and procedures. Vascular care is available at multiple sites in Calgary (Foothills Medical Centre, Rockyview General Hospital) and Edmonton (University of Alberta Hospital, Royal Alexandra Hospital). Alberta has developed a province-wide vascular access program to reduce geographic disparities.

Quebec (RAMQ)

The Régie de l'assurance maladie du Québec covers vascular testing and treatment when medically indicated. Major vascular centers include the Institut de cardiologie de Montréal, CHUM (Centre hospitalier de l'Université de Montréal), and McGill University Health Centre. Quebec has one of the more comprehensive systems of CLSC community health centers that can coordinate referrals for vascular assessment.

Saskatchewan and Manitoba

Both provinces cover medically necessary vascular testing. Vascular care is primarily available in Regina, Saskatoon, Winnipeg, and Brandon. Rural patients in these provinces often face the longest travel distances for specialist care — a significant issue given that rural Saskatchewan and Manitoba have some of Canada's highest Indigenous populations with elevated PAD risk.

Atlantic Provinces (NS, NB, PEI, NL)

All Atlantic provinces cover medically necessary vascular care. However, vascular surgery capacity is limited in PEI and NL, requiring some patients to travel to referral centers in Halifax (Nova Scotia Health Authority) or St. John's (Eastern Health).

Private Pay Options in Canada

For Canadians who wish to access vascular testing more quickly than provincial wait times allow, private vascular clinics exist in several major cities (Toronto, Vancouver, Calgary, Montreal) and typically charge CAD $200–$500 for an ABI test. These costs cannot be reimbursed by provincial health plans in most provinces.

Getting an ABI Test in Canada: Step by Step

For most Canadians, the pathway to an ABI test runs through the healthcare system:

1. Start with your family doctor or general practitioner. Describe your symptoms (if any) — leg pain with walking, cold feet, slow-healing wounds — or mention your risk factors (diabetes, smoking history, age over 65). Request an ABI test or referral to a vascular lab.
2. Your GP orders the test. They'll send a requisition to a hospital-based vascular lab or diagnostic imaging center that performs non-invasive vascular studies.
3. The vascular lab will contact you to schedule your appointment. Wait times vary from days (urgent cases with severe symptoms) to several weeks (routine screening).
4. Attend your appointment. The test takes 15–20 minutes. Results typically go back to your referring physician within a few days.
5. Follow-up with your GP or vascular specialist to review results and discuss next steps.

If you're unsatisfied with wait times or want a second opinion, you can ask your GP for a direct referral to a vascular surgeon or vascular medicine specialist. You can also ask about Doppler studies at a diagnostic imaging center if your hospital's vascular lab has a long wait.

Accessing PAD Treatment in Canada

Cardiac Rehabilitation for PAD Exercise Therapy

Unlike the US, Canada does not have a specific Medicare-equivalent coverage structure for supervised exercise therapy for PAD. However, many provinces' cardiac rehabilitation programs accept PAD patients — particularly those with coexisting coronary artery disease. Ask your cardiologist or vascular specialist for a referral to cardiac rehab.

Several Canadian academic centers have established dedicated PAD rehabilitation programs:

• University Health Network (Toronto) — PAD exercise program at Toronto Rehab
• University of Alberta Hospital (Edmonton) — Vascular rehabilitation program
• BC Heart Failure Society — supports exercise programs for vascular patients in BC

Community fitness centers, physiotherapists, and kinesiologists can also help design structured walking programs when formal supervised programs aren't available. A referral from your vascular specialist to a registered kinesiologist (RKin) or physiotherapist who specializes in cardiac/vascular rehabilitation is a practical option.

Medications — Canadian Formulary Coverage

• Statins: Atorvastatin and rosuvastatin are on all provincial drug formularies. Most provincial drug plans cover statins with varying co-payments based on income.
• Antiplatelet agents: ASA (aspirin) is inexpensive and universally available. Clopidogrel is listed on provincial formularies but may require special authorization for PAD (as opposed to post-stent) indications in some provinces.
• Rivaroxaban (COMPASS dose): Coverage for the low-dose rivaroxaban + aspirin combination for PAD varies by province. In Ontario, this requires a prior approval/exceptional access program. Other provinces are updating their formularies to align with the 2024 ACC/AHA and CCS guideline updates. Ask your specialist about your provincial coverage.
• Cilostazol (Pletal): Available in Canada but not universally listed on provincial formularies. May require special authorization or be paid out-of-pocket. Canadian list price is approximately CAD $1.50–$2.50/day.

Endovascular and Surgical Treatment

All major revascularization procedures — angioplasty, drug-coated balloon angioplasty, stenting, atherectomy, and surgical bypass — are available in Canada through the provincial health systems. These are typically performed at academic health science centers or large regional hospitals. Referral to a vascular surgeon is required and wait times for non-urgent cases vary:

• Urgent CLTI cases: typically seen within days to 1–2 weeks
• Moderate PAD with worsening symptoms: typically 4–12 weeks
• Stable claudication: may wait 3–6 months in some provinces

PAD in Indigenous Communities in Canada

Canada's First Nations, Métis, and Inuit populations face disproportionately high rates of PAD, driven largely by:

• Diabetes prevalence: Type 2 diabetes rates in First Nations communities are 3–5 times the general Canadian population, making PAD risk extremely high
• Smoking rates: Smoking prevalence in some Indigenous communities exceeds 50% — far above the national average
• Geographic barriers: Many First Nations and Inuit communities in northern Canada are remote — hundreds of kilometers from vascular specialist care — creating serious barriers to timely diagnosis and treatment
• Health system distrust: Historical trauma from the healthcare system continues to create barriers to care-seeking in some communities

The federal government's First Nations and Inuit Health Branch (FNIHB) provides supplemental health coverage for Status Indians and Inuit who are not covered by provincial plans for certain services. Several provincial governments and Indigenous health authorities are working to bring vascular screening to remote communities through telemedicine and mobile health programs.

Organizations supporting Indigenous cardiovascular health include the Canadian Indigenous Health Alliance and provincial Indigenous health authorities.

Key Canadian PAD Resources

• Heart & Stroke Foundation of Canada: heartandstroke.ca — patient resources, research funding, and advocacy for vascular disease
• Canadian Cardiovascular Society: ccs.ca — clinical guidelines and patient information
• Diabetes Canada: diabetes.ca — resources for managing diabetes-related PAD risk
• Health Canada — Tobacco Cessation: canada.ca — free smoking cessation resources including the Canada Quit Line
• Canadian Society for Vascular Surgery: csvs.ca — find a vascular surgeon and professional resources
• Dietitians of Canada: dietitians.ca — find a registered dietitian for PAD nutrition counseling